ZyVersa Therapeutics, Inc.
Navigate ZyVersa Therapeutics, Inc.
Home
About
About
Our Vision/Mission
Management Team
CEOCFO Magazine Interview With CEO
Board of Directors
Scientific Advisory Board: Inflammatory Diseases
Scientific Advisory Board: Renal Disease
Inflammasomes
Inflammasomes
IC 100: ASC Inhibitor
IC 100: MOA Video
IC 100 Infographic, Mechanism of Action
ASC Biomarker
Inflammasome Publications
White Paper: Inflammasomes, a Promising Therapeutic and Diagnostic Target
Renal Lipids
Renal Lipids
White Paper: Renal Lipids in the Pathogenesis of Kidney Disease
VAR 200, Cholesterol Efflux Mediator, 2HPβCD
Video: Renal Lipids and Kidney Disease
Cyclodextrin Publications
Renal Disease Publications
Pipeline
Pipeline
Collaboration
About FSGS
About Alport Syndrome
About Diabetic Kidney Disease
About Multiple Sclerosis
Careers
News Center
Corporate News Releases
Corporate Presentations
Media Resources
Corporate Media Contact
ZyVersa Featured Article, Business Worldwide Magazine
Contact
Home
News Center
Corporate News Releases
Corporate News Releases
Aug 3, 2022 • 7:05 AM EDT
ZyVersa's Proprietary Inflammasome ASC Inhibitor's Differentiated Mechanism of Action Featured in Translational Research Paper
Jul 27, 2022 • 7:05 AM EDT
ZyVersa Therapeutics and University of Miami Awarded a Grant from The Michael J. Fox Foundation to Determine if Inhibition of Microglial Inflammasome Activation with IC 100 Blocks Neuroinflammation Driving Parkinson's Disease Pathology
Jul 20, 2022 • 5:30 PM EDT
ZyVersa Therapeutics to Become a Publicly Traded Biopharma Company via Merger with Larkspur Health Acquisition Corp.
Jun 3, 2022 • 11:38 AM EDT
ZyVersa Therapeutics Sponsors American Diabetes Association Thought Leadership Video on Podocyte Lipotoxicity, a Cause of Diabetic Kidney Disease and Its Progression
Oct 4, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CCO, Karen A. Cashmere, Invited Speaker at Inflammasome Therapeutics Summit 2021
Sep 9, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CEO, Stephen C. Glover Invited Panel Member at Inflammasome Therapeutics Summit 2021
Sep 7, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CEO, Stephen C. Glover Invited Speaker at the H.C. Wainwright 23rd Annual Global Investment Conference, September 13-15, 2021
Aug 3, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at BTIG's Virtual Biotechnology Conference 2021
Jul 15, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at 2nd Annual LifeSci Partners' Virtual Private Company Summer Symposium July 21-23, 2021
Mar 3, 2021 • 12:55 PM EST
ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at the H.C. Wainwright Global Life Sciences Conference Being Held Virtually March 9-10, 2021